Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in Covid-19 patients: a narrative review
出版年份 2023 全文链接
标题
Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in Covid-19 patients: a narrative review
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume -, Issue -, Pages -
出版商
Informa UK Limited
发表日期
2023-11-06
DOI
10.1080/17425255.2023.2280221
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
- (2023) Edoardo Caronna et al. CEPHALALGIA
- Serum alpha-CGRP levels are increased in COVID-19 patients with headache indicating an activation of the trigeminal system
- (2023) Gabriel Gárate et al. BMC Neurology
- Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials
- (2023) Faraidoon Haghdoost et al. CEPHALALGIA
- Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
- (2023) Roberta Messina et al. CEPHALALGIA
- Long COVID and especially headache syndromes
- (2023) Claudio Tana et al. CURRENT OPINION IN NEUROLOGY
- Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
- (2023) Richard B Lipton et al. LANCET NEUROLOGY
- The Origins of Covid-19 — Why It Matters (and Why It Doesn’t)
- (2023) Lawrence O. Gostin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022
- (2023) Emily Jane Woo et al. VACCINE
- Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
- (2023) Piotr Rzymski Frontiers in Immunology
- Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods
- (2023) Ruth Link-Gelles et al. JAMA Network Open
- Primary headache disorders: From pathophysiology to neurostimulation therapies
- (2023) Ziying Wang et al. Heliyon
- Calcitonin Gene–Related Peptide Monoclonal Antibodies and Risk of SARS-CoV-2 Infection and Severe COVID-19 Outcomes Among Veterans With Migraine Disorder
- (2023) Kaicheng Wang et al. JAMA Network Open
- Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
- (2022) Queenie Fernandes et al. ANNALS OF MEDICINE
- COVID-19 related outcomes among individuals with neurodegenerative diseases: a cohort analysis in the UK biobank
- (2022) Yihan Hu et al. BMC Neurology
- Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
- (2022) CANADIAN MEDICAL ASSOCIATION JOURNAL
- Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients
- (2022) David Garcia-Azorin et al. CEPHALALGIA
- Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
- (2022) Luigi Francesco Iannone et al. CNS DRUGS
- CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
- (2022) Francesca Schiano di Cola et al. JOURNAL OF NEUROLOGY
- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection
- (2022) John P. Evans et al. Science Translational Medicine
- Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide’s Motor-Stimulating and Prosecretory Function in the Intestine
- (2022) Peter Holzer et al. Frontiers in Physiology
- Migraine
- (2022) Michel D. Ferrari et al. Nature Reviews Disease Primers
- Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysis
- (2022) Lucia Crivelli et al. Alzheimers & Dementia
- Neurological Events Reported after COVID‐19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
- (2022) Jennifer A. Frontera et al. ANNALS OF NEUROLOGY
- Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
- (2022) Fred Cohen et al. BIODRUGS
- The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic
- (2022) Ludovica Brusaferri et al. BRAIN BEHAVIOR AND IMMUNITY
- Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports
- (2022) David Garcia-Azorin et al. CEPHALALGIA
- Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients
- (2022) Ronza Najjar-Debbiny et al. CLINICAL INFECTIOUS DISEASES
- Headache associated with COVID‐19: Epidemiology, characteristics, pathophysiology, and management
- (2022) Pedro Augusto Sampaio Rocha‐Filho HEADACHE
- The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates
- (2022) Lars Jacob Stovner et al. JOURNAL OF HEADACHE AND PAIN
- Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
- (2022) Matteo Castaldo et al. JOURNAL OF HEADACHE AND PAIN
- Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
- (2022) Piero Barbanti et al. JOURNAL OF HEADACHE AND PAIN
- SARS-CoV-2 is associated with changes in brain structure in UK Biobank
- (2022) Gwenaëlle Douaud et al. NATURE
- Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
- (2022) Laura Pérez-Alós et al. Nature Communications
- Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine—A Real-Life Study
- (2022) Magdalena Nowaczewska et al. Frontiers in Neurology
- Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink
- (2022) Kayla E. Hanson et al. JAMA Network Open
- Salivary CGRP and erenumab treatment response: towards precision medicine in migraine
- (2022) Alicia Alpuente et al. ANNALS OF NEUROLOGY
- Protracted headache after COVID‐19: A case series of 31 patients from a tertiary headache center
- (2022) Leon S. Moskatel et al. HEADACHE
- Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study
- (2022) Silvia Cascini et al. JOURNAL OF ALZHEIMERS DISEASE
- Long COVID headache
- (2022) Claudio Tana et al. JOURNAL OF HEADACHE AND PAIN
- Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
- (2022) Alicia Gonzalez-Martinez et al. JOURNAL OF NEUROLOGY
- Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
- (2022) Panke Qu et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
- (2022) Brian J. Willett et al. Nature Microbiology
- Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019 (COVID-19)
- (2022) Sarju Ganatra et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of Molnupiravir in High-Risk Patients: A Propensity Score Matched Analysis
- (2022) Ronza Najjar-Debbiny et al. CLINICAL INFECTIOUS DISEASES
- Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review
- (2022) Ann M. Murray et al. Current Pain and Headache Reports
- Headache as a COVID ‐19 onset symptom and post‐ COVID ‐19 symptom in hospitalized COVID ‐19 survivors infected with the Wuhan, Alpha, or Delta SARS‐CoV ‐2 variants
- (2022) César Fernández‐de‐las‐Peñas et al. HEADACHE
- Epidemiological aspects of headache after different types of COVID ‐19 vaccines: An online survey
- (2022) Rehab Magdy et al. HEADACHE
- The relationship of headache as a symptom to COVID ‐19 survival: A systematic review and meta‐analysis of survival of 43,169 inpatients with COVID ‐19
- (2022) Víctor J. Gallardo et al. HEADACHE
- Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial
- (2022) Robert Croop et al. HEADACHE
- The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
- (2022) Nancy H. C. Loos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
- (2022) Piero Barbanti et al. JOURNAL OF HEADACHE AND PAIN
- Structural brain changes in patients with persistent headache after COVID-19 resolution
- (2022) Álvaro Planchuelo-Gómez et al. JOURNAL OF NEUROLOGY
- Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
- (2022) Carlos K H Wong et al. LANCET
- Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
- (2022) Ronen Arbel et al. NEW ENGLAND JOURNAL OF MEDICINE
- CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients
- (2022) Manuela Rizzi et al. Viruses-Basel
- Immunologic aspects of migraine: A review of literature
- (2022) Mehrnaz Salahi et al. Frontiers in Neurology
- Serum Calcitonin Gene-Related Peptide α and β Levels are Increased in COVID-19 Inpatients
- (2022) Gabriel Gárate et al. ARCHIVES OF MEDICAL RESEARCH
- Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
- (2022) Christopher C Butler et al. LANCET
- Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A Retrospective Cohort Study
- (2022) Maxime Taquet et al. NEUROLOGY
- Post-COVID-19 human memory impairment: A PRISMA-based systematic review of evidence from brain imaging studies
- (2022) Dan Shan et al. Frontiers in Aging Neuroscience
- Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination
- (2022) Alessandra Buoninfante et al. npj Vaccines
- Gepants for Acute and Preventive Migraine Treatment: A Narrative Review
- (2022) Jamir Pitton Rissardo et al. Brain Sciences
- Headache during SARS‐CoV‐2 infection as an early symptom associated with a more benign course of disease: a case‐control study
- (2021) Alicia Gonzalez‐Martinez et al. EUROPEAN JOURNAL OF NEUROLOGY
- Association between response to triptans and response to erenumab: real-life data
- (2021) Ilaria Frattale et al. JOURNAL OF HEADACHE AND PAIN
- Migraine treatment and COVID‐19 vaccines: no cause for concern
- (2021) Amy A. Gelfand et al. HEADACHE
- Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France
- (2021) Florence Esselin et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
- (2021) Ahmed Yassin et al. BMC Neurology
- Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase
- (2021) David M. Smadja et al. EUROPEAN RESPIRATORY JOURNAL
- Diagnosis and Management of Headache
- (2021) Matthew S. Robbins JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
- (2021) E. Caronna et al. NEUROLOGIA
- Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown
- (2021) Alicia Gonzalez-Martinez et al. NEUROLOGICAL SCIENCES
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Indomethacin for refractory COVID or post-COVID headache: a retrospective study
- (2021) Abouch V. Krymchantowski et al. ACTA NEUROLOGICA BELGICA
- Refractory migraine profile in CGRP‐monoclonal antibodies scenario
- (2021) Marcello Silvestro et al. ACTA NEUROLOGICA SCANDINAVICA
- Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings
- (2021) Juan I. Guerrero et al. BMC INFECTIOUS DISEASES
- The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study
- (2021) César Fernández-de-las-Peñas et al. CEPHALALGIA
- Headache as an acute and post COVID‐19 Symptom in COVID‐19 Survivors: A Meta‐analysis of the Current Literature
- (2021) César Fernández‐de‐las‐Peñas et al. EUROPEAN JOURNAL OF NEUROLOGY
- Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios
- (2021) Edoardo Caronna et al. HEADACHE
- Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
- (2021) Karin Bok et al. IMMUNITY
- HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism
- (2021) Hayrunnisa Bolay et al. JOURNAL OF HEADACHE AND PAIN
- Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis
- (2021) David García-Azorín et al. JOURNAL OF HEADACHE AND PAIN
- Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients
- (2021) Javier Trigo et al. JOURNAL OF HEADACHE AND PAIN
- Energy and reactivity profile and proton affinity analysis of rimegepant with special reference to its potential activity against SARS-CoV-2 virus proteins using molecular dynamics
- (2021) T. Pooventhiran et al. JOURNAL OF MOLECULAR MODELING
- Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review
- (2021) David García-Azorín et al. JOURNAL OF NEUROLOGY
- Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives
- (2021) Jonathan P Rogers et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
- (2021) Florence Ader et al. LANCET INFECTIOUS DISEASES
- Characterization of Headache in COVID-19: a Retrospective Multicenter Study
- (2021) Rafael César dos Anjos de Paula et al. MOLECULAR NEUROBIOLOGY
- Post-infection cognitive impairments in a cohort of elderly patients with COVID-19
- (2021) Yu-Hui Liu et al. Molecular Neurodegeneration
- Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
- (2021) Umberto Pensato et al. NEUROLOGICAL SCIENCES
- New daily persistent headache after SARS-CoV-2 infection: a report of two cases
- (2021) Fedele Dono et al. NEUROLOGICAL SCIENCES
- Atogepant for the Preventive Treatment of Migraine
- (2021) Jessica Ailani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequency and phenotype of headache in covid-19: a study of 2194 patients
- (2021) David García-Azorín et al. Scientific Reports
- Bidirectional association between migraine and rheumatoid arthritis: two longitudinal follow-up studies with a national sample cohort
- (2021) Yoo Hwan Kim et al. BMJ Open
- Predictors of response to erenumab after 12 months of treatment
- (2021) Carlo Baraldi et al. Brain and Behavior
- Changes in Cerebral Blood Flow after Erenumab Treatment in Good and Non-Responders—A Pilot Study of Migraine Patients
- (2021) Magdalena Nowaczewska et al. Journal of Clinical Medicine
- Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
- (2021) Carl H. Göbel et al. Pain and Therapy
- Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches
- (2021) Lanfranco Pellesi et al. JAMA Network Open
- Current Understanding of the Pathophysiology and Approach to Tension-Type Headache
- (2021) Stephanie J. Steel et al. Current Neurology and Neuroscience Reports
- Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research
- (2021) Edoardo Caronna et al. Current Pain and Headache Reports
- Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study
- (2021) Fabrizio Vernieri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinic and genetic predictors in response to erenumab
- (2021) Chiara Zecca et al. EUROPEAN JOURNAL OF NEUROLOGY
- Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
- (2021) Sara Bottiroli et al. JOURNAL OF HEADACHE AND PAIN
- Ischemic stroke associated with COVID-19: a systematic review and meta-analysis
- (2021) Wenzhang Luo et al. JOURNAL OF NEUROLOGY
- Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions
- (2021) Ettore Beghi et al. JOURNAL OF NEUROLOGY
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- (2021) Robert L. Gottlieb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
- (2021) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19: A Review of Potential Treatments (Corticosteroids, Remdesivir, Tocilizumab, Bamlanivimab/Etesevimab, and Casirivimab/Imdevimab) and Pharmacological Considerations
- (2021) Salin Nhean et al. JOURNAL OF PHARMACY PRACTICE
- Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
- (2020) Messoud Ashina et al. CEPHALALGIA
- Ubrogepant: First Approval
- (2020) Lesley J. Scott DRUGS
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of COVID‐19 on Parkinson's disease clinical features: a community‐based case‐control study
- (2020) Roberto Cilia et al. MOVEMENT DISORDERS
- Efficacy and safety of eptinezumab in patients with chronic migraine
- (2020) Richard B. Lipton et al. NEUROLOGY
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spectrum of Headaches Associated With SARS‐CoV‐2 Infection: Study of Healthcare Professionals
- (2020) Jesús Porta‐Etessam et al. HEADACHE
- Frequency and type of red flags in patients with Covid‐19 and headache: a series of 104 hospitalized patients
- (2020) David García‐Azorín et al. HEADACHE
- Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect
- (2020) Felix Stader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study
- (2020) Piero Barbanti et al. HEADACHE
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
- (2020) Robert Croop et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19: Coronavirus Vaccine Development Updates
- (2020) Jing Zhao et al. Frontiers in Immunology
- Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
- (2020) Danuta Szkutnik-Fiedler Pharmaceutics
- Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine
- (2020) Alicia Gonzalez-Martinez et al. PAIN MEDICINE
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
- (2019) Richard B. Lipton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ubrogepant for the Treatment of Migraine
- (2019) David W. Dodick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
- (2018) Cristina Tassorelli et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
- (2018) Christophe Depre et al. HEADACHE
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Blocking CGRP in migraine patients – a review of pros and cons
- (2017) Marie Deen et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics interactions of monoclonal antibodies
- (2016) Nicola Ferri et al. PHARMACOLOGICAL RESEARCH
- Increased risk of rheumatoid arthritis in patients with migraine: a population-based, propensity score-matched cohort study
- (2016) Yi-Chia Wang et al. RHEUMATOLOGY INTERNATIONAL
- Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
- (2015) Andrew F. Russo Annual Review of Pharmacology and Toxicology
- Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis
- (2015) Chris Cameron et al. HEADACHE
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
- (2013) Marcelo E. Bigal et al. HEADACHE
- A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
- (2012) B R Chaitman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
- (2010) Lars Edvinsson et al. CEPHALALGIA
- Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
- (2010) Jakob Møller Hansen et al. CEPHALALGIA
- Triptan Therapy in Migraine
- (2010) Elizabeth Loder NEW ENGLAND JOURNAL OF MEDICINE
- Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inhalation injury
- (2009) Matthias Lange et al. JOURNAL OF APPLIED PHYSIOLOGY
- Alteration of Neuropeptides in the Lung Tissue Correlates Brain Death-Induced Neurogenic Edema
- (2009) Anne Barklin et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now